Laminitis drug successful in trials

| May 13, 2013 | 0 Comments

LaminilA drug undergoing a clinical trial in horses has proved successful in stopping laminitis in 80 per cent of horses treated so far, it has been reported.

Laminil is an injectable drug treatment for acute and active chronic laminitis that inhibits the inflammatory response and the laminitis cascade. It has to date proven effective in treating both acute laminitis and active chronic laminitis.

The active ingredient of Laminil is already approved for use in humans by the US Food and Drug Administration (FDA), and has been approved for investigational drug testing in horses.

It is being tested in top veterinary facilities such as the Dubai Equine Hospital and the Rood & Riddle Equine Hospital in Kentucky.

It has been administered to more than 60 horses and 120 hooves with no adverse effects, proving  successful in stopping laminitis in 80 per cent of horses treated so far.

 

Read more: http://horsetalk.co.nz/2013/05/02/laminitis-drug-showing-promise-clinical-trial/

Tags:

Category: News